Lantheus Holdings, Inc. Accounts Payable and Other Accrued Liabilities, Current
Lantheus Holdings, Inc. (LNTH) had Accounts Payable and Other Accrued Liabilities, Current of $286.87 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $286.87M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $286.49M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $267.31M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $251.10M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current | Accounts Payable and Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $286.87M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $286.49M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $267.31M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $251.10M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $208.60M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $202.38M 10-Q · filed 2025-05-07 | |
| 2024-12-31 | $204.99M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $174.45M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $212.64M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $198.94M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $145.34M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $138.82M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $114.80M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $145.47M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $127.08M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $190.48M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $183.80M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $142.40M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $58.07M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $46.04M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $41.98M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $35.24M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $41.73M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $39.79M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $42.89M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $32.84M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $37.36M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $32.93M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $26.07M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $24.59M 10-Q · filed 2019-04-30 | |
| 2018-12-31 | $32.05M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $31.46M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $25.19M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $21.63M 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $26.54M 10-K · filed 2019-02-20 | |
| 2017-09-30 | $24.58M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $22.64M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $18.81M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $21.25M 10-K · filed 2018-02-26 | |
| 2016-09-30 | $21.85M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $17.66M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $14.85M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $18.50M 10-K · filed 2017-02-23 | $18.70M 10-K · filed 2016-03-02 |
| 2015-09-30 | $19.97M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $19.69M 10-Q · filed 2015-08-05 | |
| 2014-12-31 | $24.86M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |